Document is current
Any future updates will be listed below
-
Authors
Wintner, Lisa M. http://orcid.org/0000-0003-0690-4708
Giesinger, Johannes M.
Sztankay, Monika
Bottomley, Andrew
Holzner, Bernhard
,
-
Funding
Funding for this research was provided by:
European Organisation for Research and Treatment of Cancer (005-2018)
- License Information
-
More Information
Article History
Received: 27 May 2020
Accepted: 16 September 2020
First Online: 13 October 2020
Ethics approval and consent to participate
: The ethics committee of the Medical University of Innsbruck approved the trial (1020/2019, April 24, 2019). All participating centers will obtain ethical approval of their respective ethics committee in accordance with local regulations.Written, informed consent to participate will be obtained from all participants before study inclusion. It is the responsibility of the local study coordinator of each participating center to inform patients accordingly about the purpose of the study, possible risks, and benefits, to obtain the necessary data and to ensure data protection.The patient information sheet contains detailed information that all recorded data are subject to the General Data Protection Regulation (EU) 2016/679 (GDPR) and that patients can exert their rights regarding their personal data at any time (including data on contact persons and information sources). The patient information sheet and the consent form can be obtained from the corresponding author upon request.
: Not applicable.
: BH is an owner of intellectual property rights of the CHES software. The other authors do not state any competing interests.
